ANCA-associated vasculitis trials in Argentina
1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Buenos Aires, Florida, Lobos, Mar del Plata, Mendoza, Rosario, San Juan Bautista
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567